{"id":"https://openalex.org/W2589344477","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2014","title":"A phase I dose escalation study of irinotecan (CPT-11), oxaliplatin (Oxal), and capecitabine (Cap) within three UGT1A1 TA promoter cohorts (6/6, 6/7, and 7/7)","display_name":"A phase I dose escalation study of irinotecan (CPT-11), oxaliplatin (Oxal), and capecitabine (Cap) within three UGT1A1 TA promoter cohorts (6/6, 6/7, and 7/7)","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2589344477","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2014","mag":"2589344477"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.2014","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.2014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008665323","display_name":"Matthew Philip Goetz","orcid":"https://orcid.org/0000-0002-4383-270X","observed_orcids":["https://orcid.org/0000-0002-4383-270X","https://orcid.org/0000-0003-3588-024X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. P. Goetz","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026706928","display_name":"Stephanie L. Safgren","orcid":"https://orcid.org/0000-0002-5503-7324","observed_orcids":["https://orcid.org/0000-0002-5503-7324"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Safgren","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080788977","display_name":"Richard M. Goldberg","orcid":"https://orcid.org/0000-0003-0308-8223","observed_orcids":["https://orcid.org/0000-0003-0308-8223","https://orcid.org/0000-0003-3713-6895"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. M. Goldberg","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057458005","display_name":"Axel F. Grothey","orcid":"https://orcid.org/0000-0002-9341-6499","observed_orcids":["https://orcid.org/0000-0002-9341-6499"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. F. Grothey","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002528975","display_name":"Sumithra J. Mandrekar","orcid":"https://orcid.org/0000-0002-7658-1134","observed_orcids":["https://orcid.org/0000-0002-7658-1134"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. J. Mandrekar","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. M. Reid","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022511085","display_name":"Charles Erlichman","orcid":"https://orcid.org/0000-0002-1687-7080","observed_orcids":["https://orcid.org/0000-0002-1687-7080"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Erlichman","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. A. Adjei","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090904568","display_name":"Joseph Rubin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Rubin","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. M. Ames","raw_affiliation_strings":["Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Coll of Medicine, Rochester, MN; Univ of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"2014","last_page":"2014"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/ugt1a1-genotype","display_name":"UGT1A1 genotype","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ugt1a1-28","display_name":"UGT1A1*28","score":0.8709999918937683},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.800000011920929},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.6990000009536743},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.45100000500679016},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.47600001096725464},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.949999988079071},{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.4690000116825104},{"id":"https://openalex.org/keywords/advanced-gastric-cancer","display_name":"advanced gastric cancer","score":0.5090000033378601},{"id":"https://openalex.org/keywords/advanced-pancreatic-cancer","display_name":"advanced pancreatic cancer","score":0.5669999718666077},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.550000011920929},{"id":"https://openalex.org/keywords/advanced-lung-cancer","display_name":"advanced lung cancer","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8423994183540344},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6587578058242798},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5924884080886841},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.5924782752990723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5703635811805725},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5249243378639221},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5056445598602295},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.4927249252796173},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4619801938533783},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.44412845373153687},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43964821100234985},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32905519008636475},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2464476227760315},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.10686793923377991}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.2014","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.2014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142100270","https://openalex.org/W1982756255","https://openalex.org/W2039734044","https://openalex.org/W2379984063","https://openalex.org/W2419341326","https://openalex.org/W2595611375","https://openalex.org/W2560259057","https://openalex.org/W2000475715","https://openalex.org/W4312909839","https://openalex.org/W130051642"],"abstract_inverted_index":{"2014":[0],"Background:":[1],"Patients":[2,431],"(pts)":[3],"with":[4,53],"the":[5,99,211,284,333,337],"UGT1A1":[6,27,42,62,329,365,371,373,375],"*28":[7,63,330],"genotype":[8,28,43,331,366],"have":[9,200],"a":[10,36],"higher":[11],"risk":[12],"of":[13,26,46,71,336,339,346],"CPT-11":[14,112,378,388,400,412,422],"induced":[15],"diarrhea":[16,232],"and":[17,49,66,81,86,113,117,158,174,187,202,234,245,271,274,283,306,321,342,351,356],"neutropenia,":[18],"but":[19],"no":[20,250,279],"validated":[21],"guidelines":[22],"exist":[23],"for":[24,96,206,224,310],"use":[25],"to":[29,40,103,303],"dose":[30,89,107,216,255,264,294,298,335,347,352],"patients":[31],"receiving":[32],"CPT-11.":[33],"We":[34],"designed":[35],"phase":[37],"I":[38],"study":[39],"develop":[41],"specific":[44],"dosing":[45],"CPT-11,":[47,340],"Oxal,":[48,341],"Cap":[50,118,382,392,404,416,426],"in":[51,432,436],"pts":[52,60,83,105,166,180,190,205,214,260,305,312,317,323],"advanced":[54],"solid":[55],"tumors.":[56],"Methods:":[57],"Potentially":[58],"eligible":[59,85],"underwent":[61,167],"genotyping":[64],"(GeneScan)":[65],"were":[67,84,131,181,194],"stratified":[68],"into":[69],"one":[70,219],"3":[72,124,188,397,407,410,411,420],"cohorts:":[73],"7/7,":[74],"6/7,":[75],"or":[76,143,193,442,445],"6/6.":[77],"Initially,":[78,177],"only":[79,285],"7/7":[80,175,213,304,311,372],"6/7":[82,97,172,248,316,355,374],"enrolled":[87],"at":[88,106,215,254,263,292],"level":[90,108,217,256,265,299,314,319,325],"1.":[91],"After":[92],"DLT":[93,221,251,262,280,435],"was":[94,101,252,281,288,301],"seen":[95,253],"pts,":[98,249,278],"trial":[100],"opened":[102],"6/6":[104,170,277,322,376],"2.":[109],"Pts":[110],"received":[111],"Oxal":[114,380,390,402,414,424],"day":[115],"1,":[116,218,257],"days":[119],"2":[120,242,266,394,399],"-":[121,385,386,398,406,418,419,428,429],"15":[122],"every":[123],"weeks.":[125],"The":[126,328,344],"following":[127],"cycle":[128,241,437],"1":[129,300,387,438],"toxicities":[130],"defined":[132],"as":[133],"DLT:":[134],"grade":[135],"(G)":[136],"4":[137,421],"ANC":[138,223],">5":[139],"days,":[140,153,226],"G4":[141,227,272],"hemoglobin":[142],"platelet,":[144],"creatinine":[145],"\u22652":[146],"x":[147],"baseline,":[148],"treatment":[149],"delay":[150],">":[151],"14":[152,204],"sensory":[154],"neuropathy":[155],"\u2265":[156,162],"G3,":[157],"any":[159],"non-hematologic":[160],"toxicity":[161,207,287],"G3.":[163],"Results:":[164],"35":[165],"UGT1A1*28":[168],"genotyping:":[169],"(49%),":[171],"(37%),":[173],"(14%).":[176],"11":[178],"(6/6)":[179],"excluded.":[182],"A":[183],"further":[184],"7":[185],"(6/7)":[186],"(7/7)":[189],"withdrew":[191],"consent":[192],"not":[195],"eligible.":[196],"To":[197],"date,":[198],"we":[199],"treated":[201],"evaluated":[203],"(table":[208],"1).":[209],"Of":[210],"two":[212],"had":[220,261],"[G4":[222],"6":[225],"nausea":[228],"(N),":[229],"vomiting":[230],"(V),":[231],"(D)":[233],"febrile":[235],"neutropenia":[236,289],"(FN)]":[237],"while":[238],"another":[239],"developed":[240],"G3":[243,286],"FN":[244],"infection.":[246],"For":[247,276],"however":[258],"1/3":[259],"(G3":[267],"D,":[268],"N,":[269],"V":[270],"dehydration":[273],"hyponatremia).":[275],"observed":[282],"(1":[290],"pt":[291],"each":[293],"level).":[295],"Per":[296],"protocol,":[297],"closed":[302],"accrual":[307],"is":[308],"ongoing":[309],"(dose":[313,318,324],"-2),":[315],"2),":[320],"4).":[326],"Conclusion:":[327],"affects":[332],"tolerable":[334],"combination":[338],"Cap.":[343],"results":[345],"de-escalation":[348],"(UGT1A1":[349,354],"7/7)":[350],"escalation":[353,362],"6/6)":[357],"will":[358],"be":[359],"reported.":[360],"Dose":[361,367,369],"schema":[363],"by":[364],"Level":[368],"(mg/m2/day)":[370],"-2":[377],"75":[379],"85":[381,391,403],"400":[383,393],"Accruing":[384,409,430],"150":[389,401,413,423],"(1)":[395,408],"Closed":[396],"800":[405,417],"120":[415,425],"1600":[427],"parentheses":[433],"experienced":[434],"Author":[439],"Disclosure":[440],"Employment":[441],"Leadership":[443],"Consultant":[444],"Advisory":[446],"Role":[447],"Stock":[448],"Ownership":[449],"Honoraria":[450],"Research":[451],"Funding":[452],"Expert":[453],"Testimony":[454],"Other":[455],"Remuneration":[456],"Pfizer,":[457],"Roche,":[458,460],"Sanofi":[459,461,462]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2025-10-10T00:00:00"}